HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Pessino Selected Research

Therapeutics

4/2011Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Pessino Research Topics

Disease

2Neoplasms (Cancer)
09/2013 - 02/2013
2Peripheral Nervous System Diseases (PNS Diseases)
09/2013 - 02/2013
2Colorectal Neoplasms (Colorectal Cancer)
04/2011 - 04/2008
1Necrosis
04/2011

Drug/Important Bio-Agent (IBA)

1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2011
1asparagine-glycine-arginineIBA
04/2011
1human CNGRC fusion protein tumor necrosis factor-alphaIBA
04/2011
1XELOXIBA
04/2011
1Capecitabine (Xeloda)FDA Link
04/2011
1Cetuximab (Erbitux)FDA Link
04/2008
1ErbB Receptors (EGF Receptor)IBA
04/2008

Therapy/Procedure

3Drug Therapy (Chemotherapy)
09/2013 - 04/2008
1Therapeutics
04/2011